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Background: The purpose of this study was to determine the prevalence of claustrophobia 
in patients undergoing magnetic resonance imaging (MRI) after coronary artery bypass graft 
(CABG) surgery.
Methods: After IRB approval, we conducted a substudy of a prospective randomized controlled 
clinical trial of 311 patients evaluating administration of tranexamic acid and early saphenous 
vein graft patency with MRI after conventional CABG surgery. Chest tube drainage was mea-
sured at 6, 12, and 24 hours after surgery. The rate of transfusion and the amount of red blood 
cells (RBC), fresh frozen plasma (FFP), and platelets transfused were recorded.
Results: A total of 237(76%) patients underwent MRI after surgery. 39 (14%, [95% CI, 10.2 
to 18.0]) patients experienced severe anxiety caused by a fear of enclosed space in the MRI 
coil necessitating termination of the procedure. Patients with claustrophobia were on average 
5 years younger. They were more likely to have diabetes mellitus and hypertension. Patients 
with claustrophobia had increased chest tube drainage during the postoperative period. The rate 
of blood product transfusion was similar between the two groups but patients with claustro-
phobia who were transfused received signiﬁ  cantly more RBC and FFP than patients without 
claustrophobia.
Conclusions: Postoperative claustrophobia and anxiety, leading to inability to undergo MRI, 
may be more common than previously described.
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Introduction
Magnetic resonance imaging (MRI) is increasingly used as a tool for assessing both 
ischemic brain injury as well as coronary graft patency after coronary revascularization 
surgery. Claustrophobia and anxiety related symptoms are frequent causes of failure 
in completing postoperative MRI. The reported incidence of anxiety-related reactions 
during MRI ranges from 4% to 30% in the general population with 3%–5% of patients 
unable to complete MRI examination (Hricak and Amparo 1984; Quirk et al 1989; 
Melendez and McCrank 1993).
Difﬁ  culty in completing the MRI assessment may lead to underestimation of the 
true incidence of neurological injury and graft patency after coronary artery bypass 
graft (CABG) surgery.
The aim of this study was to determine the prevalence of new onset claustrophobia 
in patients undergoing MRI after CABG surgery and to evaluate any contributing 
factors.
Materials and methods
This is a substudy of a prospective randomized controlled clinical trial of 311 patients 
scheduled for elective CABG surgery with cardiopulmonary bypass (CPB) evaluating Neuropsychiatric Disease and Treatment 2008:4(2) 488
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the effects of tranexamic acid (TA) on early saphenous vein 
graft patency after surgery (Karski et al 2005). During the 
original study, all patients were preoperatively screened for 
signs of claustrophobia. The detailed interview about a fear 
of enclosed places was conducted. All patients were shown 
photographs of the MRI coil, and were given meticulous 
description and explanation of the MRI suite and the pro-
cedure itself. Patients with preoperative history of claustro-
phobia were excluded.
Other exclusion criteria were bleeding disorders, preop-
erative anemia, symptomatic peripheral vascular disease, 
connective tissue disease, age over 80 years, impaired renal 
and liver functions, history of psychiatric disorders and con-
gestive heart failure, and known contraindications to MRI. 
Postoperative MRI was used to assess saphenous vein graft 
patency in the early postoperative period when patients were 
awake, extubated and hemodynamically stable.
Based on presence or absence of new onset claustropho-
bia during the MRI procedure, patients were classed into two 
groups: claustrophobia group and controls.
All patients received premedication with lorazepam 2 mg 
1–2 h prior to surgery. Anesthetic technique was standardized 
to include fentanyl 10–20 mcg/kg, midazolam 0.1 mg/kg, 
pancuronium 0.15–0.20 mg/kg, and isoﬂ  urane 0.5%–1.5%. 
After surgery, patients were transferred to intensive care unit 
(ICU) for postoperative ventilation. Sedation was achieved 
with propofol infusion 0.5–4 mg/kg/h and morphine boluses. 
Patients were extubated according to the following criteria: 
patient responsive and cooperative, SaO2   94% with FiO2 
  60%, complete reversal of neuromuscular blockade, PaCO2 
35–55 mmHg, stable hemodynamics, absence of uncontrolled 
arrhythmia, and nasopharyngeal temperature  36 °C.
Anticoagulation was achieved with heparin to maintain an 
activated clotting time (ACT) above 480 seconds. The CPB 
circuit was primed with 1.8 L of Ringer’s lactate solution 
and 50 cc of 20% mannitol. Albumin (25%) and synthetic 
colloids (Pentaspan®; Bristol-Myers Squibb) were added to 
the circuit as needed. Management of CPB included systemic 
temperature drift to 34 °C, alpha-stat pH management, tar-
geted mean perfusion pressure between 50–70 mmHg, and 
pump ﬂ  ow rates of 2.0–2.4 L/min/m2. Myocardial protection 
was achieved with intermittent antegrade, and occasionally 
retrograde blood cardioplegia. After separation from CPB, 
heparin was neutralized with protamine 1 mg per 100 U of 
heparin, to achieve an ACT within 10% of the baseline.
Red blood cell concentrates were transfused to maintain 
hematocrit concentration at or above 20% during CPB, and 
at or above 24%–27% after CPB. Indication for platelet 
transfusion included a platelet count of  50 × 103/mm3, 
and a platelet count  80 × 103/mm3 in the presence of 
ongoing hemorrhage after complete reversal of heparin with 
protamine. Fresh frozen plasma was transfused to bleeding 
patients if the INR   1.5 after complete neutralization of 
heparin with protamine. After surgery, chest tube drainage 
was collected in a sterile cardiotomy reservoir and autotrans-
fused if drainage exceeded 150 ml for the ﬁ  rst 6 hours after 
surgery. Total chest tube drainage was measured at 6, 12, 
and 24 hours after surgery. The rate of transfusion as well 
as the amount of red blood cells (RBC), fresh frozen plasma 
(FFP), and platelet transfusion were recorded for up to 24 
hours after surgery.
Statistical analyses were performed using the SPSS sys-
tem (SPSS Inc., Chicago, IL). Comparability of both groups 
was tested with chi-square statistics on qualitative variables 
and one-way analysis of variance on quantitative variables. 
P value of 0.05 was considered statistically signiﬁ  cant.
Results
A total of 237 (76%) patients underwent coronary MRI 
procedure 5–30 days after surgery. There was no differ-
ence between the claustrophobia and controls groups with 
respect to the timing of MRI procedure. Median time for 
claustrophobia group was 13 days (range, 5–30 days), and 
10 days for controls (range, 5–30 days), p = 0.84. None of 
these patients received any sedation before, during or after 
MRI assessment. 74 (24%) patients did not undergo MRI 
procedure; 39 (14%, [95% CI, 10.2 to 18.0]) patients started 
MRI assessment but were unable to ﬁ  nish it due to severe 
anxiety caused by a fear of enclosed space in the MRI coil. 
However, as soon as these patients were removed from the 
MRI coil, the anxiety subsided without requirements for any 
medication. 35 (10%; [95% CI, 8.8 to 16.6]) patients did not 
have MRI for a variety of reasons (16 patients refused to 
have MRI; 2 patients required permanent pacemaker inser-
tion; 1 patient had cochlear implants; 2 patients had stroke; 
4 patients died; and 10 patients had no MRI slot available) 
(Figure 1).
Patients with claustrophobia were on average 5 years 
younger. They were more likely to have diabetes mellitus 
and hypertension. There was no difference in gender, body 
surface area, left ventricle function, preoperative creatinine, 
and hematological parameters between the two groups. His-
tory of active smoking, self-reported alcohol consumption, and 
benzodiazepine treatment were similar between the two groups 
(Table 1). Patients with claustrophobia had increased chest 
tube drainage during the 6, 12, and 24 hours postoperatively   Neuropsychiatric Disease and Treatment 2008:4(2) 489
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(Figure 2). The rate of blood product transfusion was similar 
between the two groups (Table 2). However, patients with 
claustrophobia who were transfused received signiﬁ  cantly 
more volume of RBC and FFP than patients without claustro-
phobia (Figure 3). There was no difference in the discharge 
plasma hemoglobin concentration between the claustrophobia 
and control groups, respectively (93.5 ± 17.5 vs. 95.5 ± 13.8; 
p = 0.4). The rates of postoperative myocardial infarction, 
atrial ﬁ  brillation, stroke, and duration of hospital length of 
stay were similar between the two groups.
Discussion
The main ﬁ  nding of this study was that the overall incidence 
of claustrophobia leading to cancellation of postoperative 
MRI was 14% (39/276). The rate of claustrophobia in our 
study considerably exceeded the previously reported rates 
of anxiety reactions in adult patients referred for MRI pro-
cedures either for clinical or research purposes varying from 
1.2% to 5%. (Hricak and Amparo 1984; Brennan et al 1988; 
Quirk et al 1989; Kilborn and Labbe 1990; Melendez and 
McCrank 1993).
All patients studied
(n = 311)
Patients that did not undergo
MRI after surgery
(n = 74)
Patients that did undergo
MRI after surgery
(n = 237)
Claustrophobia
(n = 39)
14%
(95% CI, 10.2 to 18.0)
Other causes
(n = 35)
10%
(95% CI, 8.8 to 16.6)
N = 16, refused to have MRI
N = 2, required permanent pacemaker
insertion
N = 1, cochlear implants
N=2 s t r o k e
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The clinical range of neurological abnormalities after 
cardiac surgery varies from mild behavioral changes to clini-
cally apparent stroke. Claustrophobia is classed as an anxiety 
related disorder. Anxiety is often a consequence of cardiac 
surgery with the reported incidence in the ﬁ  rst week after 
CABG surgery of 37% (Andrew et al 2000). The pathophysi-
ology of new onset anxiety after cardiac surgery is uncertain. 
However, one can hypothesize that postoperative anxiety 
disorders including claustrophobia may be a manifestation of 
mild neurological impairment secondary to embolism, brain 
hypoperfusion, cerebral edema, and inﬂ  ammatory response 
associated with CPB. Yin and colleagues (2007) found that 
patients undergoing CABG surgery with CPB suffered from 
more anxiety than patients without CPB.
Most of the previous studies on MRI-associated anxiety 
and claustrophobia have been concentrating on psychological 
aspects of these conditions (Quirk et al 1989; Kilborn and 
Labbe 1990; Melendez and McCrank 1993).
However, new onset claustrophobia after cardiac surgery 
with CPB could be potentially triggered by other mechanisms 
like neurological injury or inﬂ  ammatory response. Another 
mechanism of postoperative anxiety might be linked to 
perioperative use of different sedative medications (eg, ben-
zodiazepines, narcotic analgesics). However, postoperative 
Table 1 Demographic variables and surgical characteristics. Data is expressed as mean ± standard deviation or number of patients (%)
Claustrophobia group (n = 39) Controls (n = 237) P value
Baseline characteristics
Age, yr 55.8 ± 9.8 60.2 ± 8.2 0.005
Male, n (%) 33 (85) 213 (90) NS
Body surface area, m² 1.9 ± 0.18 1.9 ± 0.18 NS
Left ventricular grade (1–4) 1.9 ± 0.18 1.9 ± 0.17 NS
Active smoking, n (%) 3 (7.6) 42 (17.5) NS
Alcohol consumption ( 2 drink/day), n (%) 5 (12.5) 52 (21) NS
Coexisting illness, n (%)
Diabetes 17 (43) 64 (27) 0.05
Hypertension 27 (69) 123 (52) 0.045
Peripheral vascular disease 11 (28) 76 (32) NS
Myocardial infarction 18 (46) 114 (48) NS
Stroke 1 (2.5) 5 (2.1) NS
Preoperative medication, n (%)
Beta blockers 24 (61) 140 (59) NS
Calcium channel blockers 17 (44) 96 (40) NS
Aspirin 31 (79) 194 (82) NS
NSAIDs 1 (2.5) 4 (1.7) NS
Benzodiazepines 2 (5) 22 (9.2) NS
Preoperative laboratory variables
Hemoglobin, g/dL 140.7 ± 14.7 142.9 ± 11.4 NS
Platelet count, 103/mm3 229 ± 66.7 226 ± 55.0 NS
Prothrombin time, sec 11.0 ± 1.3 10.9 ± 1.2 NS
Partial thromboplastin time, sec 32.9 ± 21.5 31.4 ± 20.4 NS
Creatinine, mg/dL 88.7 ± 16.7 93.2 ± 18.4 NS
Intraoperative variables
CPB time (min) 83.5 ± 19.8 80.1 ± 20.4 NS
Cross clamp time (min) 65.2 ± 16.1 63.8 ± 17.7 NS
Minimum temperature during cardiopulmonary 
bypass, °C
33.8 ± 0.8 33.5 ± 1.2 NS
Saphenous vein grafts, n 2.8 ± 0.72 2.7 ± 0.72 NS
Abbreviations: NS, not signiﬁ  cant; NSAIDs, nonsteroidal anti-inﬂ  ammatory drugs.Neuropsychiatric Disease and Treatment 2008:4(2) 491
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sedation and pain control was standardized according to the 
current institutional practice. Furthermore, there was no dif-
ference with respect to preoperative use of benzodiazepines, 
alcohol consumption and smoking between the two groups. 
It has been previously reported that administration of ben-
zodiazepine sedation prior to MRI procedure considerably 
decreased the incidence of claustrophobia (Francis and 
Pennell 2000). However, none of the patients in our study 
received any sedation prior to MRI. The anxiety subsided 
without any medication as soon as the patients were removed 
from the MRI coil.
Interestingly, patients who developed claustrophobia 
were transfused signiﬁ  cantly greater volume of RBC and 
FFP than the controls. Furthermore, there was a trend 
towards increased rate of shed blood transfusion in patients 
with claustrophobia. Unprocessed shed blood contains high 
levels of cellular debris and lipid microparticulates (Booke 
et al 1997), which have been shown to cause microembo-
lization to the brain blood vessels (Brooker et al 1998). 
Recently, we showed that processing of shed blood with 
a continuous ﬂ  ow cell-saver resulted in better preserva-
tion of cognitive function in patients undergoing CABG 
surgery (Djaiani et al 2007). It is recognized that allogenic 
blood transfusion and reinfusion of shed blood exacerbate 
inﬂ  ammatory response mediated by cardiac surgery and 
CPB. Fransen and colleagues (1999) reported that packed 
red cell transfusion during cardiac surgery exacerbated the 
perioperative release of inﬂ  ammatory mediators. Wester-
berg and colleagues (2004) have demonstrated that plasma 
concentrations of tumor necrosis factor-α, interleukin-6, and 
C3a were elevated in all patients after CABG surgery with 
CPB, but signiﬁ  cantly more in patients receiving autotrans-
fusion postoperatively. There is growing body of evidence 
indicating that activation of inﬂ  ammatory response media-
tors is involved in the pathophysiology of anxiety-related 
reactions (Maes et al 1998, 1999; Bluthe 2000a). Studies 
in animals and humans clearly have demonstrated that 
activation of proinﬂ  ammatory cytokines, may induce anhe-
donia, depressive symptoms, and anxiety (Maes et al 1998, 
1999; Bluthe et al 2000a, 2000b). Furthermore, Maes and 
colleagues (2000) has demonstrated that women with post-
partum anxiety had signiﬁ  cantly higher serum interleukin-6 
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Figure 2 Comparison of chest tube drainage at 6, 12, and 24 hours after surgery.
Table 2 Blood product transfusion rates in patients with and without 
claustrophobia. Data is expressed as number of patients (%)
  Claustrophobia  Controls   P value
 group  (n  = 39)  (n = 237)
Red blood cells  7 (18)  45 (19)  NS
Platelets  2 (5)  4 (1.7)  NS
Fresh frozen plasma  3 (7)  10 (4)  NS
Shed blood  8 (20)  28 (12)  NS
Abbreviation: NS, not signiﬁ  cant.Neuropsychiatric Disease and Treatment 2008:4(2) 492
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Figure 3 Comparison of the amount (mL) of blood product transfusion.
Notes: *p = 0.001; **p = 0.008.
Abbreviations: RBC, red blood cells; FFP, fresh frozen plasma.
and interleukin-1 receptor antagonist levels than parturients 
without anxiety. It is possible that one of the mechanisms of 
postoperative anxiety and claustrophobia may be associated 
with activation of inﬂ  ammatory system triggered by transfu-
sion of blood products and shed blood.
This study has several limitations. First, we did not 
formally measure level of preoperative anxiety in our 
patients, the factor that can signiﬁ  cantly inﬂ  uence post-
operative anxiety related reactions. However, all patients 
were screened for signs of claustrophobia. The detailed 
interview about a fear of enclosed places was conducted. 
All patients were shown photographs of the MRI coil, and 
were given meticulous description and explanation of the 
MRI suite and the procedure itself. Furthermore, patients 
with preoperative history of claustrophobia were excluded. 
Second, we did not perform a formal neuropsychological 
examination of patients with claustrophobia. However, 
the present sample size of 39 patients with claustrophobia 
was too small to make a deﬁ  nitive statement regarding 
the neurocognitive function. Third, there were 16 patients 
who refused to have the MRI procedure after surgery. It is 
possible that these patients did not want to undergo MRI 
procedure due to elevated anxiety levels, and consequently 
the prevalence of claustrophobia could have even been 
higher than currently reported. Fourth, we did not measure 
plasma levels of inﬂ  ammatory markers perioperatively. 
Consequently, the causality of an association between 
inﬂ  ammatory response, organic brain injury and postopera-
tive anxiety related reactions would require further testing 
in future studies.
In summary, the overall rate of new onset claustrophobia 
leading to cancellation of MRI after cardiac surgery was 
14% (95% CI, 10.2 to 18.0). Based on our observations, 
postoperative claustrophobia and anxiety leading to inabil-
ity to complete MRI procedure may be more common than 
previously described. Further investigations are required 
to identify contributing factors and potential treatment 
modalities in reducing the incidence of new onset claus-
trophobia.
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